Clinical Trial

High Fructose Corn Syrup and Obesity

Study Description

Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.

To study the effects of liraglutide on neural responses to high fructose corn syrup (HFCS) in individuals with obesity.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Liraglutide

Liraglutide will be supplied in the following package sizes containing disposable, pre-filled, multidose pens. Each individual pen delivers doses of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg or 3 mg (6 mg/mL, 3 mL). Liraglutide will be self-administered daily for 12 weeks under the following regimen: 0.6mg for 1 week, 1.2mg for 1 week, 1.8mg for 1 week, 2.4mg for 1 week, 3.0mg until week 12.

Additional Information

Official Study Title

Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.

Clinical Trial ID

NCT03500484

ParticipAid ID

wdLLvd